Viva Biotech buys back 1.48 million shares on 3 June; total 21.62 million repurchased since 8 May

Bulletin Express06-03 18:22

Viva Biotech Holdings (Viva Biotech) reported no change in its total issued share capital as of 3 June 2026, which remains at 2.13 billion ordinary shares.

On 3 June 2026, the company repurchased 1.48 million shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.22 to HKD 1.26 per share, for a total consideration of HKD 1.82 million. These shares are designated for cancellation.

Including this latest transaction, Viva Biotech has bought back 21.62 million shares between 8 May and 3 June 2026 that are pending cancellation. The cumulative repurchases represent approximately 1.02 % of the company’s issued shares outstanding on 12 June 2025—the date when shareholders granted authority for up to 212.84 million shares to be repurchased. The utilised portion of the mandate thus stands at roughly 10 %.

A 30-day moratorium on new share issues or treasury-share sales remains in effect until 3 July 2026, in accordance with Hong Kong Stock Exchange rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184943479?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184943479","market":"hk","top_or_hot":-1,"title":"Viva Biotech buys back 1.48 million shares on 3 June; total 21.62 million repurchased since 8 May","media":"Bulletin Express","content":"<p>Viva Biotech Holdings (Viva Biotech) reported no change in its total issued share capital as of 3 June 2026, which remains at 2.13 billion ordinary shares.</p>\n<p>On 3 June 2026, the company repurchased 1.48 million shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.22 to HKD 1.26 per share, for a total consideration of HKD 1.82 million. These shares are designated for cancellation.</p>\n<p>Including this latest transaction, Viva Biotech has bought back 21.62 million shares between 8 May and 3 June 2026 that are pending cancellation. The cumulative repurchases represent approximately 1.02 % of the company’s issued shares outstanding on 12 June 2025—the date when shareholders granted authority for up to 212.84 million shares to be repurchased. The utilised portion of the mandate thus stands at roughly 10 %.</p>\n<p>A 30-day moratorium on new share issues or treasury-share sales remains in effect until 3 July 2026, in accordance with Hong Kong Stock Exchange rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viva Biotech buys back 1.48 million shares on 3 June; total 21.62 million repurchased since 8 May</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViva Biotech buys back 1.48 million shares on 3 June; total 21.62 million repurchased since 8 May\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viva Biotech Holdings (Viva Biotech) reported no change in its total issued share capital as of 3 June 2026, which remains at 2.13 billion ordinary shares.</p>\n<p>On 3 June 2026, the company repurchased 1.48 million shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.22 to HKD 1.26 per share, for a total consideration of HKD 1.82 million. These shares are designated for cancellation.</p>\n<p>Including this latest transaction, Viva Biotech has bought back 21.62 million shares between 8 May and 3 June 2026 that are pending cancellation. The cumulative repurchases represent approximately 1.02 % of the company’s issued shares outstanding on 12 June 2025—the date when shareholders granted authority for up to 212.84 million shares to be repurchased. The utilised portion of the mandate thus stands at roughly 10 %.</p>\n<p>A 30-day moratorium on new share issues or treasury-share sales remains in effect until 3 July 2026, in accordance with Hong Kong Stock Exchange rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1184943479","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184943479","pubTimestamp":1780482176,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Viva Biotech Holdings (Viva Biotech) reported no change in its total issued share capital as of 3 June 2026, which remains at 2.13 billion ordinary shares. On 3 June 2026, the company repurchased...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01873":"维亚生物"},"translate_title":"维亚生物于6月3日回购148万股；5月8日以来累计回购2162万","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01873":1},"content_text":"Viva Biotech Holdings (Viva Biotech) reported no change in its total issued share capital as of 3 June 2026, which remains at 2.13 billion ordinary shares.\nOn 3 June 2026, the company repurchased 1.48 million shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.22 to HKD 1.26 per share, for a total consideration of HKD 1.82 million. These shares are designated for cancellation.\nIncluding this latest transaction, Viva Biotech has bought back 21.62 million shares between 8 May and 3 June 2026 that are pending cancellation. The cumulative repurchases represent approximately 1.02 % of the company’s issued shares outstanding on 12 June 2025—the date when shareholders granted authority for up to 212.84 million shares to be repurchased. The utilised portion of the mandate thus stands at roughly 10 %.\nA 30-day moratorium on new share issues or treasury-share sales remains in effect until 3 July 2026, in accordance with Hong Kong Stock Exchange rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184943479","isCrawlerRequest":true}